Evaluation for Lynch syndrome can be initiated by immunohistochemistry for MSH2, MLH1, PMS2, MSH6 and microsatellite instability testing, or by direct germline genetic analysis for MSH2, MLH1, PMS2, MSH6 and EPCAM [130]. This evidence concerns the gene MLH1 and Lynch syndrome.